SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Abiomed Inc – ‘10-Q’ for 9/30/19 – ‘XML’

On:  Thursday, 10/31/19, at 4:13pm ET   ·   For:  9/30/19   ·   Accession #:  1564590-19-39144   ·   File #:  1-09585

Previous ‘10-Q’:  ‘10-Q’ on 8/1/19 for 6/30/19   ·   Next:  ‘10-Q’ on 2/6/20 for 12/31/19   ·   Latest:  ‘10-Q’ on 11/3/22 for 9/30/22

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/31/19  Abiomed Inc                       10-Q        9/30/19   79:11M                                    ActiveDisclosure/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.12M 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     29K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     29K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     27K 
48: R1          Document and Entity Information                     HTML     77K 
25: R2          Condensed Consolidated Balance Sheets               HTML    122K 
34: R3          Condensed Consolidated Balance Sheets               HTML     46K 
                (Parenthetical)                                                  
77: R4          Condensed Consolidated Statements of Operations     HTML     81K 
51: R5          Condensed Consolidated Statements of Comprehensive  HTML     44K 
                Income                                                           
27: R6          Condensed Consolidated Statements of Stockholders'  HTML    109K 
                Equity                                                           
36: R7          Condensed Consolidated Statements of Cash Flows     HTML    122K 
74: R8          Nature of Business                                  HTML     28K 
52: R9          Basis of Preparation and Summary of Significant     HTML     33K 
                Accounting Policies                                              
71: R10         Net Income Per Share                                HTML    126K 
61: R11         Revenue Recognition                                 HTML    125K 
14: R12         Cash Equivalents, Marketable Securities and Fair    HTML    468K 
                Value Measurements                                               
41: R13         Property and Equipment                              HTML     62K 
70: R14         Goodwill, In-Process Research and Development and   HTML    144K 
                Other Assets                                                     
60: R15         Leases                                              HTML    100K 
13: R16         Accrued Expenses                                    HTML     59K 
40: R17         Stockholders' Equity                                HTML     27K 
69: R18         Stock-Based Compensation                            HTML    214K 
62: R19         Income Taxes                                        HTML     96K 
19: R20         Commitments and Contingencies                       HTML     41K 
30: R21         Segment and Enterprise Wide Disclosures             HTML     28K 
73: R22         Basis of Preparation and Summary of Significant     HTML    118K 
                Accounting Policies (Policies)                                   
46: R23         Net Income Per Share (Tables)                       HTML    124K 
18: R24         Revenue Recognition (Tables)                        HTML     91K 
29: R25         Cash Equivalents, Marketable Securities and Fair    HTML    468K 
                Value Measurements (Tables)                                      
72: R26         Property and Equipment (Tables)                     HTML     62K 
45: R27         Goodwill, In-Process Research and Development and   HTML    137K 
                Other Assets (Tables)                                            
20: R28         Leases (Tables)                                     HTML     97K 
28: R29         Accrued Expenses (Tables)                           HTML     57K 
42: R30         Stock-Based Compensation (Tables)                   HTML    219K 
16: R31         Income Taxes (Tables)                               HTML     92K 
57: R32         Net Income Per Share - Additional Information       HTML     27K 
                (Detail)                                                         
66: R33         Computation of Basic and Diluted Net Income Per     HTML     52K 
                Share (Detail)                                                   
43: R34         Revenue Recognition - Schedule of Categorizes       HTML     32K 
                Revenue by Major Business Line (Detail)                          
17: R35         Revenue Recognition - Schedule of Categorizes       HTML     32K 
                Revenue by Major Geographical Location (Detail)                  
58: R36         Revenue Recognition - Terms - Additional            HTML     38K 
                Information (Detail)                                             
67: R37         Revenue Recognition - Deferred Revenue -            HTML     29K 
                Additional Information (Detail)                                  
44: R38         Cash Equivalents and Marketable Securities          HTML     33K 
                (Detail)                                                         
15: R39         Investable Cash Equivalents and Marketable          HTML     59K 
                Securities (Detail)                                              
31: R40         Financial Instruments Measured at Fair Value        HTML     67K 
                (Detail)                                                         
22: R41         Cash Equivalents, Marketable Securities and Fair    HTML     31K 
                Value Measurements - Additional Information                      
                (Detail)                                                         
53: R42         Valuation Method Used to Calculate Level 3          HTML     71K 
                Liabilities Measured at Estimated Fair Value of                  
                Contingent Consideration Related to Acquisition                  
                (Detail)                                                         
78: R43         Change in Fair Value of Contingent Consideration    HTML     39K 
                as Determined by Level 3 Inputs (Detail)                         
32: R44         Components of Property and Equipment (Detail)       HTML     49K 
23: R45         Goodwill, In-Process Research and Development and   HTML     66K 
                Other Assets - Additional Information (Detail)                   
54: R46         Carrying Value of Goodwill and Change in Balance    HTML     29K 
                (Detail)                                                         
79: R47         Carrying value of In-Process Research and           HTML     28K 
                Development (Detail)                                             
33: R48         Summary of Other Assets (Detail)                    HTML     33K 
21: R49         Equity Method and Other Investments Classified as   HTML     33K 
                Other Assets (Detail)                                            
11: R50         Carrying value of Other Investments (Detail)        HTML     31K 
39: R51         Supplemental Balance Sheet Information Related to   HTML     32K 
                Operating Leases (Detail)                                        
65: R52         Leases - Additional Information (Details)           HTML     29K 
56: R53         Maturities of Operating Lease Liabilities           HTML     48K 
                (Details)                                                        
10: R54         Minimum Future Lease Payments (Detail)              HTML     44K 
38: R55         Accrued Expenses (Detail)                           HTML     45K 
64: R56         Stockholders' Equity - Additional Information       HTML     36K 
                (Detail)                                                         
55: R57         Stock-Based Compensation Recognized (Detail)        HTML     34K 
12: R58         Summary of Stock Option Activity (Detail)           HTML     79K 
37: R59         Stock-Based Compensation - Additional Information   HTML     55K 
                (Detail)                                                         
76: R60         Summary of Weighted Average Grant-Date Fair Values  HTML     39K 
                And Weighted Average Assumptions Used to Calculate               
                Fair Value of Options Granted (Detail)                           
50: R61         Summary of Restricted Stock Units Activity          HTML     49K 
                (Detail)                                                         
26: R62         Income Taxes - Additional Information (Detail)      HTML     33K 
35: R63         Differences Between Statutory Income Tax Rate and   HTML     44K 
                Effective Income Tax Rate (Detail)                               
75: R64         Commitments and Contingencies - Additional          HTML     30K 
                Information (Detail)                                             
49: R65         Segment and Enterprise Wide Disclosures -           HTML     39K 
                Additional Information (Detail)                                  
63: XML         IDEA XML File -- Filing Summary                      XML    146K 
47: XML         XBRL Instance -- abmd-10q_20190930_htm               XML   3.33M 
24: EXCEL       IDEA Workbook of Financial Reports                  XLSX     79K 
 6: EX-101.CAL  XBRL Calculations -- abmd-20190930_cal               XML    195K 
 7: EX-101.DEF  XBRL Definitions -- abmd-20190930_def                XML    363K 
 8: EX-101.LAB  XBRL Labels -- abmd-20190930_lab                     XML   1.08M 
 9: EX-101.PRE  XBRL Presentations -- abmd-20190930_pre              XML    833K 
 5: EX-101.SCH  XBRL Schema -- abmd-20190930                         XSD    148K 
68: JSON        XBRL Instance as JSON Data -- MetaLinks              301±   489K 
59: ZIP         XBRL Zipped Folder -- 0001564590-19-039144-xbrl      Zip    191K

‘XML’   —   IDEA XML File — Filing Summary

This Document is an IDEA XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<FilingSummary>
<Version> 3.19.3 </Version>
<ProcessingTime/>
<ReportFormat> html </ReportFormat>
<ContextCount> 191 </ContextCount>
<ElementCount> 365 </ElementCount>
<EntityCount> 1 </EntityCount>
<FootnotesReported> false </FootnotesReported>
<SegmentCount> 51 </SegmentCount>
<ScenarioCount> 0 </ScenarioCount>
<TuplesReported> false </TuplesReported>
<UnitCount> 5 </UnitCount>
<MyReports>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R1.htm </HtmlFileName>
<LongName> 100000 - Document - Document and Entity Information </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DocumentDocumentAndEntityInformation </Role>
<ShortName> Document and Entity Information </ShortName>
<MenuCategory> Cover </MenuCategory>
<Position> 1 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R2.htm </HtmlFileName>
<LongName> 100010 - Statement - Condensed Consolidated Balance Sheets </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets </Role>
<ShortName> Condensed Consolidated Balance Sheets </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 2 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R3.htm </HtmlFileName>
<LongName> 100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical </Role>
<ShortName> Condensed Consolidated Balance Sheets (Parenthetical) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 3 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R4.htm </HtmlFileName>
<LongName> 100030 - Statement - Condensed Consolidated Statements of Operations </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperations </Role>
<ShortName> Condensed Consolidated Statements of Operations </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 4 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R5.htm </HtmlFileName>
<LongName> 100040 - Statement - Condensed Consolidated Statements of Comprehensive Income </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncome </Role>
<ShortName> Condensed Consolidated Statements of Comprehensive Income </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 5 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R6.htm </HtmlFileName>
<LongName> 100050 - Statement - Condensed Consolidated Statements of Stockholders' Equity </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity </Role>
<ShortName> Condensed Consolidated Statements of Stockholders' Equity </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 6 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R7.htm </HtmlFileName>
<LongName> 100060 - Statement - Condensed Consolidated Statements of Cash Flows </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows </Role>
<ShortName> Condensed Consolidated Statements of Cash Flows </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 7 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R8.htm </HtmlFileName>
<LongName> 100070 - Disclosure - Nature of Business </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureNatureOfBusiness </Role>
<ShortName> Nature of Business </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 8 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R9.htm </HtmlFileName>
<LongName> 100080 - Disclosure - Basis of Preparation and Summary of Significant Accounting Policies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureBasisOfPreparationAndSummaryOfSignificantAccountingPolicies </Role>
<ShortName> Basis of Preparation and Summary of Significant Accounting Policies </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 9 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R10.htm </HtmlFileName>
<LongName> 100090 - Disclosure - Net Income Per Share </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureNetIncomePerShare </Role>
<ShortName> Net Income Per Share </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 10 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R11.htm </HtmlFileName>
<LongName> 100100 - Disclosure - Revenue Recognition </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureRevenueRecognition </Role>
<ShortName> Revenue Recognition </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 11 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R12.htm </HtmlFileName>
<LongName> 100110 - Disclosure - Cash Equivalents, Marketable Securities and Fair Value Measurements </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureCashEquivalentsMarketableSecuritiesAndFairValueMeasurements </Role>
<ShortName> Cash Equivalents, Marketable Securities and Fair Value Measurements </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 12 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R13.htm </HtmlFileName>
<LongName> 100120 - Disclosure - Property and Equipment </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosurePropertyAndEquipment </Role>
<ShortName> Property and Equipment </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 13 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R14.htm </HtmlFileName>
<LongName> 100130 - Disclosure - Goodwill, In-Process Research and Development and Other Assets </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureGoodwillInProcessResearchAndDevelopmentAndOtherAssets </Role>
<ShortName> Goodwill, In-Process Research and Development and Other Assets </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 14 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R15.htm </HtmlFileName>
<LongName> 100140 - Disclosure - Leases </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureLeases </Role>
<ShortName> Leases </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 15 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R16.htm </HtmlFileName>
<LongName> 100150 - Disclosure - Accrued Expenses </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureAccruedExpenses </Role>
<ShortName> Accrued Expenses </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 16 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R17.htm </HtmlFileName>
<LongName> 100160 - Disclosure - Stockholders' Equity </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureStockholdersEquity </Role>
<ShortName> Stockholders' Equity </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 17 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R18.htm </HtmlFileName>
<LongName> 100170 - Disclosure - Stock-Based Compensation </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureStockBasedCompensation </Role>
<ShortName> Stock-Based Compensation </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 18 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R19.htm </HtmlFileName>
<LongName> 100180 - Disclosure - Income Taxes </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureIncomeTaxes </Role>
<ShortName> Income Taxes </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 19 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R20.htm </HtmlFileName>
<LongName> 100190 - Disclosure - Commitments and Contingencies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureCommitmentsAndContingencies </Role>
<ShortName> Commitments and Contingencies </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 20 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R21.htm </HtmlFileName>
<LongName> 100200 - Disclosure - Segment and Enterprise Wide Disclosures </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureSegmentAndEnterpriseWideDisclosures </Role>
<ShortName> Segment and Enterprise Wide Disclosures </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 21 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R22.htm </HtmlFileName>
<LongName> 100210 - Disclosure - Basis of Preparation and Summary of Significant Accounting Policies (Policies) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureBasisOfPreparationAndSummaryOfSignificantAccountingPoliciesPolicies </Role>
<ShortName> Basis of Preparation and Summary of Significant Accounting Policies (Policies) </ShortName>
<MenuCategory> Policies </MenuCategory>
<ParentRole> http://www.abiomed.com/20190930/taxonomy/role/DisclosureBasisOfPreparationAndSummaryOfSignificantAccountingPolicies </ParentRole>
<Position> 22 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R23.htm </HtmlFileName>
<LongName> 100220 - Disclosure - Net Income Per Share (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureNetIncomePerShareTables </Role>
<ShortName> Net Income Per Share (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.abiomed.com/20190930/taxonomy/role/DisclosureNetIncomePerShare </ParentRole>
<Position> 23 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R24.htm </HtmlFileName>
<LongName> 100230 - Disclosure - Revenue Recognition (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureRevenueRecognitionTables </Role>
<ShortName> Revenue Recognition (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.abiomed.com/20190930/taxonomy/role/DisclosureRevenueRecognition </ParentRole>
<Position> 24 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R25.htm </HtmlFileName>
<LongName> 100240 - Disclosure - Cash Equivalents, Marketable Securities and Fair Value Measurements (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureCashEquivalentsMarketableSecuritiesAndFairValueMeasurementsTables </Role>
<ShortName> Cash Equivalents, Marketable Securities and Fair Value Measurements (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.abiomed.com/20190930/taxonomy/role/DisclosureCashEquivalentsMarketableSecuritiesAndFairValueMeasurements </ParentRole>
<Position> 25 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R26.htm </HtmlFileName>
<LongName> 100250 - Disclosure - Property and Equipment (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosurePropertyAndEquipmentTables </Role>
<ShortName> Property and Equipment (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.abiomed.com/20190930/taxonomy/role/DisclosurePropertyAndEquipment </ParentRole>
<Position> 26 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R27.htm </HtmlFileName>
<LongName> 100260 - Disclosure - Goodwill, In-Process Research and Development and Other Assets (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureGoodwillInProcessResearchAndDevelopmentAndOtherAssetsTables </Role>
<ShortName> Goodwill, In-Process Research and Development and Other Assets (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.abiomed.com/20190930/taxonomy/role/DisclosureGoodwillInProcessResearchAndDevelopmentAndOtherAssets </ParentRole>
<Position> 27 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R28.htm </HtmlFileName>
<LongName> 100270 - Disclosure - Leases (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureLeasesTables </Role>
<ShortName> Leases (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.abiomed.com/20190930/taxonomy/role/DisclosureLeases </ParentRole>
<Position> 28 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R29.htm </HtmlFileName>
<LongName> 100280 - Disclosure - Accrued Expenses (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureAccruedExpensesTables </Role>
<ShortName> Accrued Expenses (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.abiomed.com/20190930/taxonomy/role/DisclosureAccruedExpenses </ParentRole>
<Position> 29 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R30.htm </HtmlFileName>
<LongName> 100290 - Disclosure - Stock-Based Compensation (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureStockBasedCompensationTables </Role>
<ShortName> Stock-Based Compensation (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.abiomed.com/20190930/taxonomy/role/DisclosureStockBasedCompensation </ParentRole>
<Position> 30 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R31.htm </HtmlFileName>
<LongName> 100300 - Disclosure - Income Taxes (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureIncomeTaxesTables </Role>
<ShortName> Income Taxes (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.abiomed.com/20190930/taxonomy/role/DisclosureIncomeTaxes </ParentRole>
<Position> 31 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R32.htm </HtmlFileName>
<LongName> 100310 - Disclosure - Net Income Per Share - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureNetIncomePerShareAdditionalInformationDetail </Role>
<ShortName> Net Income Per Share - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 32 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R33.htm </HtmlFileName>
<LongName> 100320 - Disclosure - Computation of Basic and Diluted Net Income Per Share (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureComputationOfBasicAndDilutedNetIncomePerShareDetail </Role>
<ShortName> Computation of Basic and Diluted Net Income Per Share (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 33 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R34.htm </HtmlFileName>
<LongName> 100330 - Disclosure - Revenue Recognition - Schedule of Categorizes Revenue by Major Business Line (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureRevenueRecognitionScheduleOfCategorizesRevenueByMajorBusinessLineDetail </Role>
<ShortName> Revenue Recognition - Schedule of Categorizes Revenue by Major Business Line (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 34 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R35.htm </HtmlFileName>
<LongName> 100340 - Disclosure - Revenue Recognition - Schedule of Categorizes Revenue by Major Geographical Location (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureRevenueRecognitionScheduleOfCategorizesRevenueByMajorGeographicalLocationDetail </Role>
<ShortName> Revenue Recognition - Schedule of Categorizes Revenue by Major Geographical Location (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 35 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R36.htm </HtmlFileName>
<LongName> 100350 - Disclosure - Revenue Recognition - Terms - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureRevenueRecognitionTermsAdditionalInformationDetail </Role>
<ShortName> Revenue Recognition - Terms - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 36 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R37.htm </HtmlFileName>
<LongName> 100360 - Disclosure - Revenue Recognition - Deferred Revenue - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureRevenueRecognitionDeferredRevenueAdditionalInformationDetail </Role>
<ShortName> Revenue Recognition - Deferred Revenue - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 37 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R38.htm </HtmlFileName>
<LongName> 100370 - Disclosure - Cash Equivalents and Marketable Securities (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureCashEquivalentsAndMarketableSecuritiesDetail </Role>
<ShortName> Cash Equivalents and Marketable Securities (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 38 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R39.htm </HtmlFileName>
<LongName> 100380 - Disclosure - Investable Cash Equivalents and Marketable Securities (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureInvestableCashEquivalentsAndMarketableSecuritiesDetail </Role>
<ShortName> Investable Cash Equivalents and Marketable Securities (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 39 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R40.htm </HtmlFileName>
<LongName> 100390 - Disclosure - Financial Instruments Measured at Fair Value (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureFinancialInstrumentsMeasuredAtFairValueDetail </Role>
<ShortName> Financial Instruments Measured at Fair Value (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 40 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R41.htm </HtmlFileName>
<LongName> 100400 - Disclosure - Cash Equivalents, Marketable Securities and Fair Value Measurements - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureCashEquivalentsMarketableSecuritiesAndFairValueMeasurementsAdditionalInformationDetail </Role>
<ShortName> Cash Equivalents, Marketable Securities and Fair Value Measurements - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 41 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R42.htm </HtmlFileName>
<LongName> 100410 - Disclosure - Valuation Method Used to Calculate Level 3 Liabilities Measured at Estimated Fair Value of Contingent Consideration Related to Acquisition (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureValuationMethodUsedToCalculateLevel3LiabilitiesMeasuredAtEstimatedFairValueOfContingentConsiderationRelatedToAcquisitionDetail </Role>
<ShortName> Valuation Method Used to Calculate Level 3 Liabilities Measured at Estimated Fair Value of Contingent Consideration Related to Acquisition (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 42 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R43.htm </HtmlFileName>
<LongName> 100420 - Disclosure - Change in Fair Value of Contingent Consideration as Determined by Level 3 Inputs (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureChangeInFairValueOfContingentConsiderationAsDeterminedByLevel3InputsDetail </Role>
<ShortName> Change in Fair Value of Contingent Consideration as Determined by Level 3 Inputs (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 43 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R44.htm </HtmlFileName>
<LongName> 100430 - Disclosure - Components of Property and Equipment (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureComponentsOfPropertyAndEquipmentDetail </Role>
<ShortName> Components of Property and Equipment (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 44 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R45.htm </HtmlFileName>
<LongName> 100440 - Disclosure - Goodwill, In-Process Research and Development and Other Assets - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureGoodwillInProcessResearchAndDevelopmentAndOtherAssetsAdditionalInformationDetail </Role>
<ShortName> Goodwill, In-Process Research and Development and Other Assets - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 45 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R46.htm </HtmlFileName>
<LongName> 100450 - Disclosure - Carrying Value of Goodwill and Change in Balance (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureCarryingValueOfGoodwillAndChangeInBalanceDetail </Role>
<ShortName> Carrying Value of Goodwill and Change in Balance (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 46 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R47.htm </HtmlFileName>
<LongName> 100460 - Disclosure - Carrying value of In-Process Research and Development (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureCarryingValueOfInProcessResearchAndDevelopmentDetail </Role>
<ShortName> Carrying value of In-Process Research and Development (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 47 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R48.htm </HtmlFileName>
<LongName> 100470 - Disclosure - Summary of Other Assets (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureSummaryOfOtherAssetsDetail </Role>
<ShortName> Summary of Other Assets (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 48 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R49.htm </HtmlFileName>
<LongName> 100480 - Disclosure - Equity Method and Other Investments Classified as Other Assets (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureEquityMethodAndOtherInvestmentsClassifiedAsOtherAssetsDetail </Role>
<ShortName> Equity Method and Other Investments Classified as Other Assets (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 49 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R50.htm </HtmlFileName>
<LongName> 100490 - Disclosure - Carrying value of Other Investments (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureCarryingValueOfOtherInvestmentsDetail </Role>
<ShortName> Carrying value of Other Investments (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 50 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R51.htm </HtmlFileName>
<LongName> 100500 - Disclosure - Supplemental Balance Sheet Information Related to Operating Leases (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureSupplementalBalanceSheetInformationRelatedToOperatingLeasesDetail </Role>
<ShortName> Supplemental Balance Sheet Information Related to Operating Leases (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 51 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R52.htm </HtmlFileName>
<LongName> 100510 - Disclosure - Leases - Additional Information (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails </Role>
<ShortName> Leases - Additional Information (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 52 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R53.htm </HtmlFileName>
<LongName> 100520 - Disclosure - Maturities of Operating Lease Liabilities (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureMaturitiesOfOperatingLeaseLiabilitiesDetails </Role>
<ShortName> Maturities of Operating Lease Liabilities (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 53 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R54.htm </HtmlFileName>
<LongName> 100540 - Disclosure - Minimum Future Lease Payments (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureMinimumFutureLeasePaymentsDetail </Role>
<ShortName> Minimum Future Lease Payments (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 54 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R55.htm </HtmlFileName>
<LongName> 100550 - Disclosure - Accrued Expenses (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureAccruedExpensesDetail </Role>
<ShortName> Accrued Expenses (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.abiomed.com/20190930/taxonomy/role/DisclosureAccruedExpensesTables </ParentRole>
<Position> 55 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R56.htm </HtmlFileName>
<LongName> 100560 - Disclosure - Stockholders' Equity - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail </Role>
<ShortName> Stockholders' Equity - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 56 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R57.htm </HtmlFileName>
<LongName> 100570 - Disclosure - Stock-Based Compensation Recognized (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureStockBasedCompensationRecognizedDetail </Role>
<ShortName> Stock-Based Compensation Recognized (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 57 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R58.htm </HtmlFileName>
<LongName> 100580 - Disclosure - Summary of Stock Option Activity (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureSummaryOfStockOptionActivityDetail </Role>
<ShortName> Summary of Stock Option Activity (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 58 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R59.htm </HtmlFileName>
<LongName> 100590 - Disclosure - Stock-Based Compensation - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail </Role>
<ShortName> Stock-Based Compensation - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 59 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R60.htm </HtmlFileName>
<LongName> 100600 - Disclosure - Summary of Weighted Average Grant-Date Fair Values And Weighted Average Assumptions Used to Calculate Fair Value of Options Granted (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureSummaryOfWeightedAverageGrantDateFairValuesAndWeightedAverageAssumptionsUsedToCalculateFairValueOfOptionsGrantedDetail </Role>
<ShortName> Summary of Weighted Average Grant-Date Fair Values And Weighted Average Assumptions Used to Calculate Fair Value of Options Granted (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 60 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R61.htm </HtmlFileName>
<LongName> 100610 - Disclosure - Summary of Restricted Stock Units Activity (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureSummaryOfRestrictedStockUnitsActivityDetail </Role>
<ShortName> Summary of Restricted Stock Units Activity (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 61 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R62.htm </HtmlFileName>
<LongName> 100620 - Disclosure - Income Taxes - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail </Role>
<ShortName> Income Taxes - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 62 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R63.htm </HtmlFileName>
<LongName> 100630 - Disclosure - Differences Between Statutory Income Tax Rate and Effective Income Tax Rate (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureDifferencesBetweenStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateDetail </Role>
<ShortName> Differences Between Statutory Income Tax Rate and Effective Income Tax Rate (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 63 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R64.htm </HtmlFileName>
<LongName> 100640 - Disclosure - Commitments and Contingencies - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail </Role>
<ShortName> Commitments and Contingencies - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 64 </Position>
</Report>
<Report instance="abmd-10q_20190930.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R65.htm </HtmlFileName>
<LongName> 100650 - Disclosure - Segment and Enterprise Wide Disclosures - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.abiomed.com/20190930/taxonomy/role/DisclosureSegmentAndEnterpriseWideDisclosuresAdditionalInformationDetail </Role>
<ShortName> Segment and Enterprise Wide Disclosures - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 65 </Position>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<LongName> All Reports </LongName>
<ReportType> Book </ReportType>
<ShortName> All Reports </ShortName>
</Report>
</MyReports>
<InputFiles>
<File doctype="10-Q" original="abmd-10q_20190930.htm"> abmd-10q_20190930.htm </File>
<File> abmd-20190930.xsd </File>
<File> abmd-20190930_cal.xml </File>
<File> abmd-20190930_def.xml </File>
<File> abmd-20190930_lab.xml </File>
<File> abmd-20190930_pre.xml </File>
<File> abmd-ex311_8.htm </File>
<File> abmd-ex312_6.htm </File>
<File> abmd-ex321_7.htm </File>
</InputFiles>
<SupplementalFiles>
<File> glalfqywu1cv000001.jpg </File>
</SupplementalFiles>
<BaseTaxonomies>
<BaseTaxonomy> http://fasb.org/us-gaap/2019-01-31 </BaseTaxonomy>
<BaseTaxonomy> http://xbrl.sec.gov/country/2017-01-31 </BaseTaxonomy>
<BaseTaxonomy> http://fasb.org/srt/2019-01-31 </BaseTaxonomy>
<BaseTaxonomy> http://xbrl.sec.gov/dei/2019-01-31 </BaseTaxonomy>
</BaseTaxonomies>
<HasPresentationLinkbase> true </HasPresentationLinkbase>
<HasCalculationLinkbase> true </HasCalculationLinkbase>
</FilingSummary>

↑Top
Filing Submission 0001564590-19-039144   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Mon., May 13, 10:51:22.1am ET